natgillin/translations-raw huggingface dataset:
For concomitant medications which require administration via divided doses, it should be noted that the required dose of Cholestagel can be taken once a day. 
Pri sočasno uporabljenih zdravilih, ki zahtevajo odmerjanje v razdeljenih odmerkih, je treba upoštevati, da se odmerek zdravila Cholestagel lahko vzame enkrat na dan.
In these patients, monitoring vitamin A, D and E levels and assessing vitamin K status through the measurement of coagulation parameters is recommended and the vitamins should be supplemented if necessary. 
Pri njih priporočamo spremljanje koncentracije vitaminov A, D in E ter oceno stanja količine vitamina K z meritvami parametrov koagulacije ter po potrebi nadomeščanje vitaminov.
So far, no studies have been conducted that directly demonstrate whether treatment with Cholestagel as monotherapy or combination therapy has any effect on cardiovascular morbidity or mortality. 
Do sedaj niso bile izvedene študije, ki bi neposredno pokazale kakršenkoli vpliv zdravljenja z zdravilom Cholestagel, samostojno ali v kombinaciji, na srčnožilno obolevnost ali umrljivost.
There have been very rare reports of reduced phenytoin levels in patients who have received Cholestagel administered with phenytoin. 
Obstajajo zelo redka poročila o znižanih vrednostih fenitoina pri bolnikih, ki so prejemali zdravilo Cholestagel skupaj z fenitoinom.
• Ciclosporin (a medicine used to suppress the immune system). 
• ciklosporin (zdravilo, ki se uporablja za zmanjšanje delovanja imunskega sistema).
The tablets are packed in plastic bottles with child resistant closures. 
Tablete so pakirane v plastenke z za otroke varno zaporko.
Consequently, caution should be exercised when Cholestagel is used in patients with these disorders. 
Zato morate biti pri uporabi zdravila Cholestagel pri bolnikih s temi motnjami posebno pozorni.
INFORMATION IN BRAILLE Cholestagel 
PODATKI V BRAILLOVI PISAVI Cholestagel
The maximum recommended dose is 7 tablets per day. 
Najvišji priporočeni odmerek je 7 tablet dnevno.
However, in one study triglycerides tended to increase more when Cholestagel was given as a single dose with breakfast. 
Vendar je pri eni študiji prišlo do večjega zvišanja koncentracije trigliceridov pri jemanju zdravila Cholestagel v obliki enojnega odmerka ob zajtrku.
Common: Serum triglycerides increased Uncommon :Serum transaminases increased 
Pogosto: povišana koncentracija serumskih trigliceridov Občasno: povišana koncentracija serumskih transaminaz
Only constipation and dyspepsia were reported by a higher percentage among those receiving Cholestagel, compared with placebo. 
Samo o obstipaciji in dispepsiji so poročali v višjem odstotku pri tistih, ki so prejemali zdravilo Cholestagel v primerjavi s placebom.
Pharmacotherapeutic group: Lipid modifying agent, bile acid sequestrants, ATC code: C10A C 04 
Farmakoterapevtska skupina: Zdravila, ki spreminjajo raven lipidov, adsorbenti žolčnih kislin, oznaka ATC: C10AC04
• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 • Bowel or biliary obstruction 
• Preobčutljivost na zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1, • zapora črevesa ali zapora odtoka žolča.
Studies examining administration of Cholestagel as a single dose with breakfast, a single dose with dinner, or as divided doses with breakfast and dinner did not show significant differences in LDL-C reduction for different dosing schedules. 
Študije, v katerih so preučevali uporabo zdravila Cholestagel v obliki enojnega odmerka ob zajtrku, enojnega odmerka ob večerji ali ločenih odmerkov ob zajtrku in večerji, niso pokazale pomembnih razlik v znižanju koncentracije holesterola LDL pri različnih urnikih odmerjanja.
Co-administration of Cholestagel and repaglinide had no effect on the AUC and caused a 19% reduction in the Cmax of repaglinide, the clinical significance of which is unknown. 
Sočasno jemanje zdravil Cholestagel in repaglinid ni imelo nobenega vpliva na vrednosti AUC, povzročilo pa je znižanje vrednosti Cmax repaglinida za 19 %, vendar pa klinična pomembnost le-tega ni znana.
Since there is a high degree of variability in the bioavailability of verapamil, the clinical significance of this finding is unclear. 
Biološka uporabnost verapamila se zelo spreminja, zato klinična pomembnost teh rezultatov ni povsem jasna.
These could include poorly controlled diabetes, untreated hypothyroidism (low levels of thyroid hormone for which no treatment is being given currently), proteins in urine (nephrotic syndrome), altered protein levels in the blood (dysproteinaemias), and blockage of the bile transport to your gall bladder (obstructive liver disease). 
Mednje sodijo slabo nadzorovana sladkorna bolezen, nezdravljeni hipotiroidizem (nizke koncentracije tiroidnega hormona, za kar trenutno ne jemljete zdravil), beljakovine v urinu (nefrotski sindrom), spremenjene koncentracije beljakovin v krvi (disproteinemije) in zapora izločanja žolča v žolčnik (obstruktivna jetrna bolezen).
In interaction studies in healthy volunteers, Cholestagel had no effect on the bioavailability of digoxin, metoprolol, quinidine, valproic acid, and warfarin. 
V študiji medsebojnega delovanja pri zdravih prostovoljcih Cholestagel ni imel učinka na biološko uporabnost digoksina, metoprolola, kinidina, valprojske kisline in varfarina.
Reductions were also seen for non-HDL-C, Total-C and Apo B. A small 5%, non-significant increase in triglycerides was noted. 
Znižanje so opazili tudi pri vrednostih holesterola ne-HDL, celokupnega holesterola in Apo B. Opazili so manjše 5% neznačilno zvišanje trigliceridov.
Effects on triglyceride levels 
Učinek na koncentracije trigliceridov
Pack sizes are 24 (1 x 24), 100 (2 x 50) and 180 (1 x 180) tablets. 
Velikosti pakiranj so 24 (1 x 24), 100 (2 x 50) in 180 (1 x 180) tablet.
Oral contraceptive pill 
Peroralna kontracepcijska tabletka
Other medicines and Cholestagel 
Druga zdravila in zdravilo Cholestagel
Cholestagel can induce or worsen present constipation. 
Cholestagel lahko izzove ali poslabša že prisotno obstipacijo.
Cholestagel can affect the bioavailability of the oral contraceptive pill when administered simultaneously. 
Zdravilo Cholestagel lahko vpliva na biološko uporabnost peroralnih kontracepcijskih tabletk, če se jemljejo sočasno.
There are no data on the effect of Cholestagel on fertility in humans. 
Ni podatkov o vplivu zdravila Cholestagel na plodnost pri ljudeh.
This causes an increased demand for cholesterol in the liver cells, resulting in the dual effects of increasing transcription and activity of the cholesterol biosynthetic enzyme, hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase, and increasing the number of hepatic low-density lipoprotein receptors. 
To povzroči povečano potrebo po holesterolu v jetrnih celicah, kar ima dvojni učinek: poveča se prepis in aktivnost encima za biosintezo holesterola, hidroksimetil-glutaril-koencima A (HMG-CoA) reduktaze, in v jetrih se poveča število receptorjev za lipoproteine nizke gostote.
The mechanism of action for the activity of colesevelam, the active substance in Cholestagel, has been evaluated in several in vitro and in vivo studies. 
Mehanizem delovanja holesevelama, zdravilne učinkovine v zdravilu Cholestagel, so ocenili v več in vitro in in vivo študijah.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic/foetal development, 
Študije na živalih ne kažejo neposrednih ali posrednih škodljivih učinkov na nosečnost, razvoj zarodka/plodu, porod ali postnatalni razvoj (glejte poglavje 5.3).
During normal digestion, bile acids are secreted into the intestine. 
Med normalno prebavo se žolčne kisline izločajo v črevo.
The safety of Cholestagel has not been established in breast-feeding women. 
Varnost zdravila Cholestagel ni bila potrjena pri ženskah, ki dojijo.
In a 6 week study 129 patients with mixed hyperlipidaemia were randomised to fenofibrate 160 mg plus 3.8 g Cholestagel or fenofibrate alone. 
V 6-tedenski študiji so 129 bolnikom z mešano hiperlipidemijo naključno dajali kombinacijo 160 mg fenofibrata in 3,8 g zdravila Cholestagel ali pa samo fenofibrat.
The safety and efficacy of Cholestagel in patients with dysphagia, swallowing disorders, severe gastrointestinal motility disorders, inflammatory bowel disease, liver failure or major gastrointestinal tract surgery have not been established. 
Prav tako nista potrjeni varnost in učinkovitost zdravila Cholestagel pri bolnikih z disfagijo, motnjami požiranja, hudimi motnjami gibljivosti prebavil, vnetno boleznijo črevesa, okvaro jeter ali večjo operacijo prebavil.
Off-white, capsule-shaped film-coated tablets imprinted with “C625” on one side. 
Sivo-bele filmsko obložene tablete v obliki kapsul z napisom »C625« na eni strani.
Specific clinical interaction studies with colesevelam and vitamin K have not been performed. 
Posebne klinične študije medsebojnega delovanja med holesevelamom in vitaminom K niso bile izvedene.
However, caution should be exercised when treating patients with a susceptibility to vitamin K or fat-soluble vitamin deficiencies, such as patients with malabsorption. 
Vendar morate biti previdni pri zdravljenju bolnikov, pri katerih sumite na pomanjkanje vitamina K ali v maščobah topnih vitaminov, kot so na primer bolniki z okvarjeno absorpcijo.
Talk to your doctor or pharmacist before taking Cholestagel - if your triglyceride levels (a blood fat) are greater than 3.4 mmol/L - if you have difficulty in swallowing, or have a major stomach or intestinal disorder - if you suffer from constipation, as Cholestagel may induce or worsen this condition. 
Pred začetkom jemanja zdravila Cholestagel se posvetujte s svojim zdravnikom ali farmacevtom, - če je koncentracija trigliceridov (maščob v krvi) večja od 3,4 mmol/l, - če imate težave pri požiranju ali imate resno trebušno ali črevesno bolezen, - če imate težave z zapeko, saj lahko zdravilo Cholestagel povzroči ali poslabša to težavo; to je še posebej pomembno pri bolnikih s koronarno srčno boleznijo in angino pektoris.
These studies have demonstrated that colesevelam binds bile acids, including glycocholic acid, the major bile acid in humans. 
Študije so pokazale, da se holesevelam veže na žolčne kisline, vključno z glikoholno, glavno žolčno kislino pri človeku.
If you think any of these apply to you, you should inform your doctor or pharmacist before taking Cholestagel. 
Če menite, da to velja za vas, se posvetujte z zdravnikom ali farmacevtom, preden začnete jemati Cholestagel.
Before starting therapy with Cholestagel, your physician should make sure that certain conditions do not contribute to your elevated cholesterol levels. 
Pred začetkom zdravljenja z zdravilom Cholestagel se mora vaš zdravnik prepričati, da k vaši zvišani koncentraciji holesterola ne prispevajo določene bolezni.
What Cholestagel is and what it is used for What you need to know before you take Cholestagel How to take Cholestagel 
Kaj je zdravilo Cholestagel in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Cholestagel Kako jemati zdravilo Cholestagel Možni neželeni učinki
If you forget to take Cholestagel 
Če ste pozabili vzeti zdravilo Cholestagel
These compensatory effects result in increased clearance of LDL-C from the blood, resulting in decreased serum LDL-C levels. 
Ti kompenzirajoči učinki povzročijo povečanje očistka holesterola LDL iz krvi, kar pripelje do znižanja koncentracije holesterola LDL v serumu.
Clinical trials have shown that Cholestagel and statins can be co-administered or dosed apart, and that Cholestagel and ezetimibe can be coadministered or dosed apart. 
Klinična preskušanja so pokazala, da se lahko zdravilo Cholestagel jemlje skupaj ali ločeno s statini in skupaj ali ločeno z ezetimibom.
No interaction was observed when Cholestagel and pioglitazone were administered simultaneously in healthy volunteers 
Niso opazili medsebojnega delovanja ob sočasnem jemanju zdravila Cholestagel in pioglitazon pri zdravih prostovoljcih.
In a clinical study Cholestagel did not affect the faecal excretion of endogenous (hydrophilic) ursodeoxycholic acid. 
V klinični študiji zdravilo Cholestagel ni vplivalo na izločanje endogene (hidrofilne) ursodeoksiholne kisline v fecesu.
In the paediatric population, the safety and efficacy of 1.9 or 3.8 g/day Cholestagel was assessed in an 8 week multi-centre, randomised, double-blind, placebo-controlled study in 194 boys and postmenarchal girls, aged 10-17 years, with heterozygous FH on a stable dose of statins (47 patients, 24%) or treatment-naïve to lipid-lowering therapy (147 patients, 76%). 
Pri pediatrični populaciji so varnost in učinkovitost odmerkov zdravila Cholestagel 1,9 oz. 3,8 g/dan ocenjevali v 8-tedenski multicentrični, randomizirani, dvojno slepi, s placebom kontrolirani študiji pri 194 fantih in dekletih po menarhi, starih od 10 do 17 let, s heterozigotno družinsko hiperholesterolemijo, ki so prejemali stabilen odmerek statinov (47 bolnikov, 24 %) ali se še niso zdravili z zdravili za nižanje ravni lipidov (147 bolnikov, 76 %).
In addition, based on theoretical grounds Cholestagel should be administered at least 4 hours after ciclosporin in order to further minimise the risks related to the concomitant administration of ciclosporin and Cholestagel. 
Poleg tega pa se na osnovi teoretičnih razprav priporoča jemanje zdravila Cholestagel najmanj 4 ure po vzetju ciklosporina, da bi še dodatno zmanjšali tveganja povezana s sočasno uporabo ciklosporina in zdravila Cholestagel.
Very common: Flatulence*, constipation* Common: Vomiting, diarrhoea*, dyspepsia*, abdominal pain, abnormal stools, nausea, abdominal distension 
Zelo pogosto: flatulenca*, obstipacija* Pogosto: bruhanje, diareja*, dispepsija*,bolečine v trebuhu, nenormalno blato, navzea, abdominalna distenzija Občasno: disfagija
• Anticoagulant therapy (medicines, such as warfarin, used to thin blood). 
• zdravljenje z antikoagulanti (zdravila, kot je varfarin, ki se uporablja za redčenje krvi).
The dosing of the statin and the ezetimibe should follow the instructions for that particular medicine. 
Pri odmerjanju statina in ezetimiba morate upoštevati navodila za uporabo posameznega zdravila.
It should be noted that stopping Cholestagel therapy will result in increased ciclosporin blood concentrations. 
Upoštevajte, da bo prenehanje zdravljenja z zdravilom Cholestagel zvišalo vrednosti ciklosporina v krvi.
Taking Cholestagel helps to lower the level of cholesterol in your blood. 
Jemanje zdravila Cholestagel vam pomaga znižati koncentracijo holesterola v krvi.
Package sizes are: 180 tablets (1 X 180) 
Velikosti pakiranj: 180 tablet (1 x 180)
The incidence of intestinal obstruction is likely to be increased among patients with a history of bowel obstruction or removal. 
Pojavnost intestinalne obstrukcije bo verjetno višja med bolniki, ki so v preteklosti že imeli črevesno obstrukcijo ali jim je bil odstranjen del črevesja.
What Cholestagel looks like and contents of the pack 
Izgled zdravila Cholestagel in vsebina pakiranja
Co-administration of colesevelam and metformin extended-release (ER) tablets increases the exposure of metformin. 
Sočasno jemanje holesevelama in metformina v obliki tablet s podaljšanim sproščanjem (extended-release ER) poveča izpostavljenost metforminu.
• Ursodeoxycholic acid (a medicine used to dissolve gallstones or treat specific chronic liver diseases). 
• ursodeoksiholna kislina (zdravilo za raztapljanje žolčnih kamnov ali zdravljenje specifičnih kroničnih bolezni jeter).
Your doctor should only give you Cholestagel if a diet low in fat and cholesterol did not work well enough on its own. 
Zdravnik vam bo predpisal Cholestagel le, če sama dieta z malo maščob in holesterola ni bila dovolj učinkovita.
In comparison, in patients given placebo, LDL-C, Total-C, HDL-C and Apo-B were unchanged, while triglycerides increased 5%. 
Pri bolnikih, ki so prejemali placebo, se koncentracije holesterola LDL, celokupnega holesterola, holesterola HDL in Apo B niso spremenile, medtem ko se je koncentracija trigliceridov povečala za 5 %.
Co-administration of Cholestagel and glyburide (also known as glibenclamide) caused a decrease in the AUC0-inf and Cmax of glyburide by 32% and 47%, respectively. 
Sočasno jemanje zdravil Cholestagel in gliburid (znano tudi kot glibenklamid) je povzročilo znižanje vrednosti AUC0-inf gliburida za 32 % in vrednosti Cmax gliburida za 47 %.
If you are taking medicines for diabetes, you should consult with your physician so that you can be closely monitored. 
Če jemljete antidiabetična zdravila, to povejte zdravniku, da vas lahko redno nadzira.
- Cholestagel may also be used together with ezetimibe (a cholesterol-lowering medicine that works by reducing cholesterol absorption from the gut), with or without a statin. 
- Zdravilo Cholestagel se lahko uporablja tudi skupaj z ezetimibom (zdravilom za zniževanje koncentracije holesterola, ki deluje tako, da zmanjšuje absorpcijo holesterola iz prebavil) s statinom ali brez njega.
Cholestagel decreased the Cmax and AUC of sustained-release verapamil by approximately 31% and 11%, respectively. 
Cholestagel je pri verapamilu s podaljšanim sproščanjem zmanjšal cmax za približno 31 % in AUC za približno 11 %.
• Thyroid replacement therapy (medicines, such as thyroxine or levothyroxine, used to treat low thyroid hormone levels) 
• zdravljenje z nadomeščanjem hormona ščitnice (zdravila, kot je tiroksin ali levotiroksin, ki se uporablja za zdravljenje nizkih koncentracij hormona ščitnice),
If you are prescribed Cholestagel and any other medicine together you must also read the patient information leaflet that comes with that particular medicine before you start to take your medicine. 
Če so vam skupaj predpisali zdravilo Cholestagel in katerokoli drugo zdravilo, morate pred začetkom jemanja zdravila prebrati tudi navodilo za uporabo tega drugega zdravila.
If you are taking anticoagulant therapy you should consult with your physician to closely monitor anticoagulation levels, as Cholestagel may affect the absorption of vitamin K and therefore interfere with the activity of warfarin. 
Če prejemate antikoagulantno zdravljenje, se morate posvetovati s svojim zdravnikom, da bo skrbno spremljal antikoagulacijske vrednosti, saj lahko zdravilo Cholestagel vpliva na absorpcijo vitamina K in zaradi tega ovira delovanje varfarina.
NAME OF THE MEDICINAL PRODUCT Cholestagel 625 mg film-coated tablets 
IME ZDRAVILA Cholestagel 625 mg filmsko obložene tablete
Combination therapy: 
Kombinirano zdravljenje:
During therapy, the cholesterol-lowering diet should be continued, and serum total-C, LDL-C and triglyceride levels should be determined periodically during treatment to confirm favourable initial and adequate long-term responses. 
Med zdravljenjem mora bolnik nadaljevati z dieto za zniževanje holesterola, občasno pa morajo biti določene koncentracije celokupnega holesterola (total-C), holesterola LDL (LDL-C) in trigliceridov, da bi potrdili ugodne začetne in ustrezne dolgoročne odzive.
OUTER CARTON AND BOTTLE LABEL (24, 100 AND 180 TABLETS) WITH CARTON BOTTLE LABEL (180 TABLETS) WITHOUT CARTON 
PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI NALEPKA NA ŠKATLI IN PLASTENKI (24, 100 IN 180 TABLET) Z NALEPKO NA PLASTENKI (180 TABLET) BREZ ŠKATLE
If you take more Cholestagel than you should Please contact your doctor. 
Če ste vzeli večji odmerek zdravila Cholestagel, kot bi smeli Obvestite svojega zdravnika.
Iron oxide black (E172) Hypromellose (E464) Propylene glycol 
Črnilo za tisk: črni železov oksid (E172) hipromeloza (E464) propilenglikol
PHARMACEUTICAL FORM AND CONTENTS 24 film-coated tablets 
FARMACEVTSKA OBLIKA IN VSEBINA 24 filmsko obloženih tablet 100 filmsko obloženih tablet 180 filmsko obloženih tablet
The recommended dose for Cholestagel, when used with a statin or ezetimibe or both together, is 4 to 6 tablets a day by mouth. 
Priporočeni odmerek zdravila Cholestagel, ko ga jemljete skupaj s statinom ali ezetimibom ali obema skupaj, je 4 do 6 tablet dnevno, ki jih zaužijete skozi usta.
Colesevelam binds to glimepiride and reduces glimepiride absorption from the gastrointestinal tract. 
Holesevelam veže glimepirid in zmanjša absorbcijo glimepirida iz prebavil.
Hypromellose (E464) Diacetylated monoglycerides 
Filmska obloga: hipromeloza (E464) diacetilirani monogliceridi
When Cholestagel was co-administered with statins in clinical studies, an expected add-on LDL-C lowering effect was observed, and no unexpected effects were observed. 
Pri sočasni uporabi zdravila Cholestagel in statinov v kliničnih študijah so opazili pričakovan skupni učinek zniževanja koncentracije holesterola LDL (LDL-C), nepričakovanih učinkov pa niso opazili.
Caution should be exercised when prescribing to breast-feeding women. 
Pri predpisovanju zdravila ženskam, ki dojijo, je potrebna previdnost.
Therefore, Cholestagel is not recommended for use in this population. 
Zato jemanje zdravila Cholestagel v tej populaciji ni priporočljivo.
Caution should be exercised when treating patients with triglyceride levels greater than 3.4 mmol/L due to the triglyceride increasing effect with Cholestagel. 
Posebno morate biti pozorni pri zdravljenju bolnikov, ki imajo koncentracije trigliceridov nad 3,4 mmol/L, kajti Cholestagel povečuje koncentracije trigliceridov.
Patients receiving concomitant metformin ER and colesevelam should be monitored for clinical response as is usual for the use of anti-diabetes drugs. 
Bolnike, ki sočasno jemljejo metformin ER in holesevelam, je potrebno klinično nadzirati, kot je to običajno pri anti-diabetični terapiji.
If your doctor suspects that Cholestagel may have an effect on the absorption of the other medication, you may be advised to take Cholestagel at least 4 hours before or at least 4 hours after taking the other medication. 
Če bo zdravnik menil, da zdravilo Cholestagel lahko vpliva na absorpcijo drugega zdravila, vam bo morda svetoval, da zdravilo Cholestagel jemljete vsaj 4 ure pred ali vsaj 4 ure po jemanju drugega zdravila.
Prior to initiating therapy with Cholestagel, if secondary causes of hypercholesterolaemia (i.e., poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease) are considered, these should be diagnosed and properly treated. 
Če predvidevate sekundarne vzroke hiperholesterolemije (npr. slabo nadzorovan diabetes mellitus, hipotiroidizem, nefrotski sindrom, disproteinemije, obstruktivna jetrna bolezen), morate pred začetkom zdravljenja z zdravilom Cholestagel določiti diagnozo in jih ustrezno zdraviti.
Cholestagel is prescribed to treat a condition known as primary hypercholesterolaemia (when cholesterol in the blood is elevated) in adults. 
Zdravilo Cholestagel se predpisuje za zdravljenje bolezni, ki ji rečemo primarna hiperholesterolemija (nenormalno zvišana koncentracija holesterola v krvi) pri odraslih.
Triglycerides in the Cholestagel group increased by 19% and 13% at 6 and 12 weeks vs an increase of 6% and 13% in the placebo group, but the increases were not significantly different. 
Koncentracija trigliceridov se je pri bolnikih, ki so prejemali Cholestagel, po 6 tednih zvišala za 19 %, po 12 tednih pa za 13 %, v placebo skupini pa se je koncentracija trigliceridov po 6 tednih zvišala za 6 %, po 12 tednih pa za 13 %, vendar zvišanje ni bilo pomembno različno.
The recommended dose of Cholestagel for combination with a statin with or without ezetimibe is 4 to 6 tablets per day. 
Priporočeni odmerek zdravila Cholestagel v kombinaciji s statinom z ezetimibom ali brez njega je od 4 do 6 tablet dnevno.
You should take your Cholestagel tablets with food and liquid. 
Tablete Cholestagel morate jemati s hrano in tekočino.
Tablets should be taken with liquid and with a meal. 
Tablete morate jemati s tekočino in ob obroku.
Each tablet contains 625 mg colesevelam. 
Ena tableta vsebuje 625 mg holesevelama.
Before starting therapy with Cholestagel, you should be advised to follow a cholesterol-lowering diet and you should continue this diet during treatment. 
Pred začetkom zdravljenja z zdravilom Cholestagel vam morajo predpisati dieto za znižanje koncentracije holesterola, ki jo morate nadaljevati med zdravljenjem.